Skip to content

Author

G. Prakash

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

[177Lu]Lu-PSMA-617 Plus Short-Course Priming With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Single-Arm Phase 2 Trial (Lu-PRIME).

BACKGROUND [177Lu]Lu-PSMA-617 has been an approved treatment modality for metastatic castration-resistant prostate cancer (mCRPC). Recent studies have shown PSMA upregulation following enzalutamide, which may enhance the outcomes with [177Lu]Lu-PSMA-617. This study aims to evaluate the efficacy and safety of short-cour...

P. Aggarwal, A. Sood, S. Satapathy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.